ReviewClinical and experimental gastroenterology2023

Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors.

Prapassorn Thirasastr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.